These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
324 related items for PubMed ID: 16386976
1. Microdissection genotyping analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma. Tse DT, Finkelstein SD, Benedetto P, Dubovy S, Schiffman J, Feuer WJ. Am J Ophthalmol; 2006 Jan; 141(1):54-61. PubMed ID: 16386976 [Abstract] [Full Text] [Related]
2. Clinical and microdissection genotyping analyses of the effect of intra-arterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma. Tse DT. Trans Am Ophthalmol Soc; 2005 Jan; 103():337-67. PubMed ID: 17057810 [Abstract] [Full Text] [Related]
12. Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases. Nagao T, Gaffey TA, Serizawa H, Sugano I, Ishida Y, Yamazaki K, Tokashiki R, Yoshida T, Minato H, Kay PA, Lewis JE. Mod Pathol; 2003 Dec; 16(12):1265-72. PubMed ID: 14681328 [Abstract] [Full Text] [Related]
13. Clonal origin of lymph node metastases in bladder carcinoma. Jones TD, Carr MD, Eble JN, Wang M, Lopez-Beltran A, Cheng L. Cancer; 2005 Nov 01; 104(9):1901-10. PubMed ID: 16196038 [Abstract] [Full Text] [Related]
14. Chromosome 6 deletion and candidate tumor suppressor genes in adenoid cystic carcinoma. Rutherford S, Yu Y, Rumpel CA, Frierson HF, Moskaluk CA. Cancer Lett; 2006 May 18; 236(2):309-17. PubMed ID: 16054751 [Abstract] [Full Text] [Related]
15. Role of chemotherapy and molecularly targeted agents in the treatment of adenoid cystic carcinoma of the lacrimal gland. Le Tourneau C, Razak AR, Levy C, Calugaru V, Galatoire O, Dendale R, Desjardins L, Gan HK. Br J Ophthalmol; 2011 Nov 18; 95(11):1483-9. PubMed ID: 21183517 [Abstract] [Full Text] [Related]
16. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma. Ariyanayagam-Baksh SM, Baksh FK, Swalsky PA, Finkelstein SD. Mod Pathol; 2003 Oct 18; 16(10):992-5. PubMed ID: 14559981 [Abstract] [Full Text] [Related]
17. Adenoid cystic carcinoma of the lacrimal gland: MYB gene activation, genomic imbalances, and clinical characteristics. von Holstein SL, Fehr A, Persson M, Therkildsen MH, Prause JU, Heegaard S, Stenman G. Ophthalmology; 2013 Oct 18; 120(10):2130-8. PubMed ID: 23725736 [Abstract] [Full Text] [Related]
18. Genome Sequencing and Apoptotic Markers to Assess Treatment Response of Lacrimal Gland Adenoid Cystic Carcinoma to Intra-Arterial Cytoreductive Chemotherapy. Yu MD, Men CJ, Do H, Colevas AD, Lin JH, Egbert PR, Tse DT, Kossler AL. Ophthalmic Plast Reconstr Surg; 2013 Oct 18; 38(2):e44-e47. PubMed ID: 34798653 [Abstract] [Full Text] [Related]
19. Microdissection-based allelotyping: a novel technique to determine the temporal sequence and biological aggressiveness of colorectal cancer. Gamblin TC, Finkelstein SD, Upsal N, Kaye JD, Blumberg D. Am Surg; 2006 May 18; 72(5):445-53. PubMed ID: 16719202 [Abstract] [Full Text] [Related]
20. Deletion of 1p32-p36 is the most frequent genetic change and poor prognostic marker in adenoid cystic carcinoma of the salivary glands. Rao PH, Roberts D, Zhao YJ, Bell D, Harris CP, Weber RS, El-Naggar AK. Clin Cancer Res; 2008 Aug 15; 14(16):5181-7. PubMed ID: 18698036 [Abstract] [Full Text] [Related] Page: [Next] [New Search]